Global Medical REIT Statistics
Total Valuation
GMRE has a market cap or net worth of $433.84 million. The enterprise value is $1.15 billion.
Important Dates
The next confirmed earnings date is Tuesday, November 4, 2025, after market close.
Earnings Date | Nov 4, 2025 |
Ex-Dividend Date | Sep 29, 2025 |
Share Statistics
GMRE has 13.86 million shares outstanding. The number of shares has increased by 1.54% in one year.
Current Share Class | 13.41M |
Shares Outstanding | 13.86M |
Shares Change (YoY) | +1.54% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 0.38% |
Owned by Institutions (%) | 72.95% |
Float | 12.61M |
Valuation Ratios
The trailing PE ratio is 93.53 and the forward PE ratio is 120.69. GMRE's PEG ratio is 17.55.
Price/FFO Ratio | n/a |
Price/AFFO Ratio | n/a |
PE Ratio | 93.53 |
Forward PE | 120.69 |
PS Ratio | 3.00 |
Forward PS | 2.86 |
PB Ratio | 1.00 |
P/TBV Ratio | 1.16 |
P/FCF Ratio | n/a |
P/OCF Ratio | 6.21 |
PEG Ratio | 17.55 |
Financial Ratio History Enterprise Valuation
EV / Earnings | 257.90 |
EV / Sales | 8.12 |
EV / EBITDA | 13.37 |
EV / EBIT | 34.04 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 1.38.
Current Ratio | 1.32 |
Quick Ratio | 1.21 |
Debt / Equity | 1.38 |
Debt / EBITDA | 8.00 |
Debt / FCF | n/a |
Interest Coverage | 1.13 |
Financial Efficiency
Return on equity (ROE) is 1.93% and return on invested capital (ROIC) is 1.73%.
Return on Equity (ROE) | 1.93% |
Return on Assets (ROA) | 1.67% |
Return on Invested Capital (ROIC) | 1.73% |
Return on Capital Employed (ROCE) | 2.70% |
Revenue Per Employee | $5.46M |
Profits Per Employee | $171,846 |
Employee Count | 26 |
Asset Turnover | 0.11 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.37% in the last 52 weeks. The beta is 1.22, so GMRE's price volatility has been higher than the market average.
Beta (5Y) | 1.22 |
52-Week Price Change | -33.37% |
50-Day Moving Average | 34.93 |
200-Day Moving Average | 36.84 |
Relative Strength Index (RSI) | 39.57 |
Average Volume (20 Days) | 288,878 |
Short Selling Information
The latest short interest is 773,188, so 5.58% of the outstanding shares have been sold short.
Short Interest | 773,188 |
Short Previous Month | 558,370 |
Short % of Shares Out | 5.58% |
Short % of Float | 6.13% |
Short Ratio (days to cover) | 3.45 |
Income Statement
In the last 12 months, GMRE had revenue of $141.90 million and earned $4.47 million in profits. Earnings per share was $0.34.
Revenue | 141.90M |
Gross Profit | 141.74M |
Operating Income | 33.85M |
Pretax Income | 10.65M |
Net Income | 4.47M |
EBITDA | 86.19M |
EBIT | 33.85M |
Earnings Per Share (EPS) | $0.34 |
Full Income Statement Balance Sheet
The company has $16.98 million in cash and $726.59 million in debt, giving a net cash position of -$709.61 million or -$51.21 per share.
Cash & Cash Equivalents | 16.98M |
Total Debt | 726.59M |
Net Cash | -709.61M |
Net Cash Per Share | -$51.21 |
Equity (Book Value) | 525.02M |
Book Value Per Share | 32.02 |
Working Capital | 14.32M |
Full Balance Sheet Cash Flow
Operating Cash Flow | 71.24M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 99.89%, with operating and profit margins of 23.85% and 7.25%.
Gross Margin | 99.89% |
Operating Margin | 23.85% |
Pretax Margin | 7.51% |
Profit Margin | 7.25% |
EBITDA Margin | 60.74% |
EBIT Margin | 23.85% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $3.00, which amounts to a dividend yield of 9.56%.
Dividend Per Share | $3.00 |
Dividend Yield | 9.56% |
Dividend Growth (YoY) | -14.29% |
Years of Dividend Growth | n/a |
Payout Ratio | 1,072.97% |
Buyback Yield | -1.54% |
Shareholder Yield | 7.85% |
Earnings Yield | 1.01% |
FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for GMRE is $47.92, which is 53.05% higher than the current price. The consensus rating is "Buy".
Price Target | $47.92 |
Price Target Difference | 53.05% |
Analyst Consensus | Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 4.04% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside | |
Stock Splits
The last stock split was on September 22, 2025. It was a reverse split with a ratio of 1:5.
Last Split Date | Sep 22, 2025 |
Split Type | Reverse |
Split Ratio | 1:5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 5 |